Dean S M, Olin J W, Piedmonte M, Grubb M, Young J R
Department of Vascular Medicine, Cleveland Clinic Foundation, OH 44195, USA.
J Vasc Surg. 1996 Jan;23(1):28-34, discussion 34-5. doi: 10.1016/s0741-5214(05)80032-1.
Data from our institution and elsewhere have demonstrated that ultrasound-guided compression closure (UGCC) is an effective method of treating postcatheterization pseudoaneurysms. Whereas patients receiving anticoagulation do not have as high a success rate as those not receiving anticoagulants, there have been no large series evaluating the factors associated with success or failure in patients receiving anticoagulation. The purpose of this study is to determine whether uninterrupted anticoagulation interferes with successful UGCC of pseudoaneurysms and to identify factors associated with success or failure.
From May 1991 to September 1994, 238 cases of attempted UGCC of pseudoaneurysms were performed in our vascular laboratory. Only patients who received uninterrupted heparin, warfarin, or both at the time of pseudoaneurysm compression were eligible for inclusion into the study. Seventy-seven patients were identified who met the study criteria.
Successful pseudoaneurysm compression was obtained in 56 (73%) patients, whereas 21 (27%) patients had a failed UGCC. In the successfully treated group, seven (12.5%) required between two to three compression attempts to induce sustained thrombosis. There was no statistical difference in age, sex, sheath size, days after procedure, location of pseudoaneurysm, or number of chambers in the pseudoaneurysm between those patients who had a successful repair and those who did not. If the pseudoaneurysm was less than 4 cm in diameter, 51 of 65 patients (78%) had a successful repair compared with 5 of 12 patients (42%) with a pseudoaneurysm of 4 cm or greater (p = 0.013). There was no statistical difference between success and failure in patients receiving warfarin alone (3.73 mean international normalized ratio, 72% success rate), heparin alone (mean activated partial thromboplastin time of 63 seconds, 92% success rate), or heparin and warfarin (mean activated partial thromboplastin time of 70 seconds, mean international normalized ratio of 4, success rate of 67%). No arterial or venous thrombosis occurred during pseudoaneurysm compression.
Successful UGCC of pseudoaneurysms occurred in a large percentage of patients receiving full-dose, uninterrupted anticoagulation. The only factor influencing success was the size of the pseudoaneurysm.
我们机构及其他地方的数据表明,超声引导下压迫闭合术(UGCC)是治疗导管插入术后假性动脉瘤的有效方法。接受抗凝治疗的患者成功率不如未接受抗凝治疗的患者高,但尚无大型系列研究评估接受抗凝治疗患者成功或失败的相关因素。本研究的目的是确定持续抗凝是否会干扰假性动脉瘤UGCC的成功实施,并确定与成功或失败相关的因素。
1991年5月至1994年9月,我们血管实验室对238例假性动脉瘤进行了UGCC尝试。只有在假性动脉瘤压迫时接受持续肝素、华法林或两者治疗的患者才有资格纳入本研究。确定了77例符合研究标准的患者。
56例(73%)患者假性动脉瘤压迫成功,而21例(27%)患者UGCC失败。在成功治疗组中,7例(12.5%)需要两到三次压迫尝试才能诱导持续血栓形成。成功修复的患者与未成功修复的患者在年龄、性别、鞘管大小、术后天数、假性动脉瘤位置或假性动脉瘤腔数方面无统计学差异。如果假性动脉瘤直径小于4 cm,65例患者中有51例(78%)修复成功,而假性动脉瘤直径为4 cm或更大的12例患者中有5例(42%)修复成功(p = 0.013)。单独接受华法林治疗(平均国际标准化比值为3.73,成功率为72%)、单独接受肝素治疗(平均活化部分凝血活酶时间为63秒,成功率为92%)或同时接受肝素和华法林治疗(平均活化部分凝血活酶时间为70秒,平均国际标准化比值为4,成功率为67%)的患者,成功与失败之间无统计学差异。假性动脉瘤压迫期间未发生动脉或静脉血栓形成。
在接受全剂量、持续抗凝治疗的大部分患者中,假性动脉瘤UGCC成功。影响成功的唯一因素是假性动脉瘤的大小。